Acknowledgements • Arthur J. Moss, MD • Ilan Goldenberg, MD • David T. Huang, MD • Scott D. Solomon, MD • Scott McNitt, MS • Slava Polonsky, MS • Mehmet Aktas, MD • Alon Barsheshet, MD • Christine Tompkins, MD • Wojciech Zareba, MD, PhD 14
References • Shiga, T and Kasanuki, H: Drug therapy for ventricular tachyarrhythmia in heart failure. Circulation journal : <strong>of</strong>ficial journal <strong>of</strong> the Japanese Circulation Society 2007; 71 Suppl A:A90-6. • Higgins, SL, Yong, P, Sheck, D, et al: Biventricular pacing diminishes the need for implantable cardioverter defibrilla<strong>to</strong>r therapy. Ventak CHF Investiga<strong>to</strong>rs. Journal <strong>of</strong> the American College <strong>of</strong> Cardiology 2000; 36:824-827. • Arya, A, Haghjoo, M, Dehghani, MR, et al: Effect <strong>of</strong> cardiac resynchronization therapy on the incidence <strong>of</strong> ventricular arrhythmias in patients <strong>with</strong> an implantable cardioverter-defibrilla<strong>to</strong>r. Heart rhythm : the <strong>of</strong>ficial journal <strong>of</strong> the Heart Rhythm Society 2005; 2:1094- 1098. • Kies, P, Bax, JJ, Molhoek, SG, et al: Effect <strong>of</strong> left ventricular remodeling after cardiac resynchronization therapy on frequency <strong>of</strong> ventricular arrhythmias. The American Journal <strong>of</strong> Cardiology 2004; 94:130-132. • Di Biase, L, Gasparini, M, Lunati, M, et al: Antiarrhythmic effect <strong>of</strong> reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrilla<strong>to</strong>r) Italian Registry. Journal <strong>of</strong> the American College <strong>of</strong> Cardiology 2008; 52:1442-1449. • Solomon, SD, Foster, E, Bourgoun, M, et al: Effect <strong>of</strong> cardiac resynchronization therapy on reverse remodeling and relation <strong>to</strong> outcome: multicenter au<strong>to</strong>matic defibrilla<strong>to</strong>r implantation trial: cardiac resynchronization therapy. Circulation 2010; 122:985-992. • Barsheshet, A, Wang, PJ, Moss, AJ, et al: Reverse Remodeling and the Risk <strong>of</strong> <strong>Ventricular</strong> Tachyarrhythmias in the MADIT-CRT (Multicenter Au<strong>to</strong>matic Defibrilla<strong>to</strong>r Implantation Trial-<strong>Cardiac</strong> Resynchronization Therapy). Journal <strong>of</strong> the American College <strong>of</strong> Cardiology 2011; 57:2416-2423. • Aktas, MK, Kim, DD, McNitt, S, et al: <strong>Right</strong> ventricular dysfunction and the incidence <strong>of</strong> implantable cardioverter-defibrilla<strong>to</strong>r therapies. Pacing and clinical electrophysiology : PACE 2009; 32:1501-1508. • Moss, AJ, Brown, MW, Cannom, DS, et al: Multicenter au<strong>to</strong>matic defibrilla<strong>to</strong>r implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical pro<strong>to</strong>col. Annals <strong>of</strong> Noninvasive Electrocardiology : The Official Journal <strong>of</strong> the International Society for Holter and Noninvasive Electrocardiology, Inc 2005; 10:34-43. • Lang, RM, Bierig, M, Devereux, RB, et al: Recommendations for chamber quantification: a report from the American Society <strong>of</strong> Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction <strong>with</strong> the European Association <strong>of</strong> Echocardiography, a branch <strong>of</strong> the European Society <strong>of</strong> Cardiology. Journal <strong>of</strong> the American Society <strong>of</strong> Echocardiography : <strong>of</strong>ficial publication <strong>of</strong> the American Society <strong>of</strong> Echocardiography 2005; 18:1440-1463. 15